EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Engineered Probiotic‐Based Personalized Cancer Vaccine Potentiates Antitumor Immunity through Initiating Trained Immunity

Zhaoxia Chen, Tuying Yong, Zhaohan Wei, Xiaoqiong Zhang, Xin Li, Jiaqi Qin, Jianye Li, Jun Hu, Xiangliang Yang, Lu Gan iD

Advanced Science · 2024-01 · 11 (3)

DOI: 10.1002/advs.202305081 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 27.11.2023. Verfasst von Zhaoxia Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, …. Hauptthemen laut MEDLINE: Cancer Vaccines, Neoplasms, Probiotics. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer vaccines hold great potential for clinical cancer treatment by eliciting T cell‐mediated immunity. However, the limited numbers of antigen‐presenting cells (APCs) at the injection sites, the insufficient tumor antigen phagocytosis by APCs, and the presence of a strong tumor immunosuppressive microenvironment severely compromise the efficacy of cancer vaccines. Trained innate immunity may promote tumor antigen‐specific adaptive immunity. Here, a personalized cancer vaccine is developed by engineering the inactivated probiotic Escherichia coli Nissle 1917 to load tumor antigens and β‐glucan, a trained immunity inducer. After subcutaneous injection, the cancer vaccine delivering model antigen OVA (BG/OVA@EcN) is highly accumulated and phagocytosed by macrophages at the injection sites to induce trained immunity. The trained macrophages may recruit dendritic cells (DCs) to facilitate BG/OVA@EcN phagocytosis and the subsequent DC maturation and T cell activation. In addition, BG/OVA@EcN remarkably enhances the circulating trained monocytes/macrophages, promoting differentiation into M1‐like macrophages in tumor tissues. BG/OVA@EcN generates strong prophylactic and therapeutic efficacy to inhibit tumor growth by inducing potent adaptive antitumor immunity and long‐term immune memory. Importantly, the cancer vaccine delivering autologous tumor antigens efficiently prevents postoperative tumor recurrence. This platform offers a facile translatable strategy to efficiently integrate trained immunity and adaptive immunity for personalized cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer VaccinesNeoplasmsProbioticsHumansTrained ImmunityDendritic CellsAntigens, NeoplasmLymphocyte ActivationTumor Microenvironment

Stichwörter der Autor:innen

antitumor immunitycancer vaccinesprobioticstrained immunityβ-glucan

Substanzen

Cancer VaccinesAntigens, Neoplasm

Autor:innen und Institutionen

  • National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074, China.
  • Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074, China.
  • Hubei Key Laboratory of Bioinorganic Chemistry and Materia Medica, Huazhong University of Science and Technology, Wuhan, 430074, China.

ORCID-Profile: Lu Gan

Förderung

  • National Key R&D Program of China
  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Chen, Z., Yong, T., Wei, Z., Zhang, X., Li, X., Qin, J., Li, J., Hu, J., Yang, X., & Gan, L. (2024). Engineered Probiotic‐Based Personalized Cancer Vaccine Potentiates Antitumor Immunity through Initiating Trained Immunity. Advanced Science, 11(3). https://doi.org/10.1002/advs.202305081

Vancouver

Chen Z, Yong T, Wei Z, Zhang X, Li X, Qin J, et al. Engineered Probiotic‐Based Personalized Cancer Vaccine Potentiates Antitumor Immunity through Initiating Trained Immunity. Advanced Science. 2024;11(3). doi:10.1002/advs.202305081

BibTeX
@article{Chen2024,
  author = {Chen, Zhaoxia and Yong, Tuying and Wei, Zhaohan and Zhang, Xiaoqiong and Li, Xin and Qin, Jiaqi and Li, Jianye and Hu, Jun and Yang, Xiangliang and Gan, Lu},
  title = {Engineered Probiotic‐Based Personalized Cancer Vaccine Potentiates Antitumor Immunity through Initiating Trained Immunity},
  journal = {Advanced Science},
  year = {2024},
  volume = {11},
  number = {3},
  doi = {10.1002/advs.202305081}
}
Kostenlos starten →